曲伏帕治疗慢性肝病。
Trofopar treatment of chronic liver diseases.
作者信息
Loghinov A S, Suhareva G V, Bendikov E A, Blok I E, Astasenkova C J, Nicolaeva A P
机构信息
Central Unional Institute for Gastroenterology, Moscow, USSR.
出版信息
Rom J Intern Med. 1991 Jan-Jun;29(1-2):65-74.
PMID:1947713
Abstract
The clinical study on the Romanian product Trofopar was performed on 71 patients affected by chronic liver diseases; of them 30 patients suffered from cirrhosis decompensated at the parenchymal and vascular level. The clinical results corroborated with laboratory tests substantiate the efficacy of Trofopar, which improves liver blood circulation, increases the capacity of hepatocyte regeneration, detoxification and metabolization.
摘要
针对罗马尼亚产品Trofopar开展了一项针对71名慢性肝病患者的临床研究；其中30名患者存在实质和血管层面失代偿的肝硬化。临床结果与实验室检测结果相互印证，证实了Trofopar的疗效，其可改善肝脏血液循环，提高肝细胞再生、解毒及代谢能力。
Zotero 插件